11.000
+0,00%
2026-10-19
Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +46.0% | +2.6% | 2 / 3 | -41.0% | +12.95 pp | +5.78 pp | +9.3% | 0.00 | 10.24 | 107 | −41,0% | 10,4 | +46,0% | 10.24 | 9.26 | +10,6% |
| Pts | 8 | 0 | 8 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 11.000 (close price on 2026-10-19)EPS (TTM): 1.074
Financial charts
1.Revenue & growth
VND bn106Q2/26
1.Revenue & growth
VND bn106Q2/26
2.Profit & growth
VND bn9,92Q2/26
3.Profit mix (Penman)
VND bn38,0Q2/26
4.Margins & cost structure
%24.4%Q2/26
5.Returns & cash cycle
% · days33.4%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn416Q2/26
8.Funding & debt health
VND bn · times416Q2/26
9.Revenue backlog
VND bn11,0Q2/26
10.Valuation
times · %10,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %349Q2/26
Adjusted EPS growth, latest quarter
39.9%
Average adjusted EPS growth, 3 quarters
0.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26